Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Oncoimmunology
|
April 14, 2017
PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas
François Bertucci, Pascal Finetti, Delphine Perrot, et al.
Cancer
|
October 15, 2010
Trends in survival for patients with metastatic soft-tissue sarcoma
Antoine Italiano, Simone Mathoulin-Pelissier, Axel Le Cesne, et al.
The American Journal of Surgical Pathology
|
December 28, 2002
Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group
Marie-Josée Terrier-Lacombe, Louis Guillou, Georges Maire, et al.
American Journal of Clinical Pathology
|
January 15, 2009
Epithelioid sarcoma: a clinicopathologic and immunohistochemical analysis of 106 cases from the French sarcoma group
Laila Chbani, Louis Guillou, Philippe Terrier, et al.
The Oncologist
|
August 22, 2012
Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)
Patricia Pautier, Anne Floquet, Nicolas Penel, et al.
The American Journal of Surgical Pathology
|
March 15, 2014
Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas
Agnès Neuville, Françoise Collin, Patrick Bruneval, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043)
Stefan Sleijfer, Isabelle Ray-Coquard, Zsuzsa Papai, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 13, 2012
Localised angiosarcomas: the identification of prognostic factors and analysis of treatment impact. A retrospective analysis from the French Sarcoma Group (GSF/GETO)
Clothilde Lindet, Agnès Neuville, Nicolas Penel, et al.
The American Journal of Surgical Pathology
|
August 28, 2007
Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group
Louis Guillou, Jean Benhattar, Carole Gengler, et al.
Acta Oncologica (Stockholm, Sweden)
|
April 23, 2017
Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study
Robin J Young, Saskia Litière, Michela Lia, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Oncoimmunology
|
April 14, 2017
PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas
François Bertucci, Pascal Finetti, Delphine Perrot, et al.
Cancer
|
October 15, 2010
Trends in survival for patients with metastatic soft-tissue sarcoma
Antoine Italiano, Simone Mathoulin-Pelissier, Axel Le Cesne, et al.
The American Journal of Surgical Pathology
|
December 28, 2002
Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group
Marie-Josée Terrier-Lacombe, Louis Guillou, Georges Maire, et al.
American Journal of Clinical Pathology
|
January 15, 2009
Epithelioid sarcoma: a clinicopathologic and immunohistochemical analysis of 106 cases from the French sarcoma group
Laila Chbani, Louis Guillou, Philippe Terrier, et al.
The Oncologist
|
August 22, 2012
Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)
Patricia Pautier, Anne Floquet, Nicolas Penel, et al.
The American Journal of Surgical Pathology
|
March 15, 2014
Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas
Agnès Neuville, Françoise Collin, Patrick Bruneval, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043)
Stefan Sleijfer, Isabelle Ray-Coquard, Zsuzsa Papai, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 13, 2012
Localised angiosarcomas: the identification of prognostic factors and analysis of treatment impact. A retrospective analysis from the French Sarcoma Group (GSF/GETO)
Clothilde Lindet, Agnès Neuville, Nicolas Penel, et al.
The American Journal of Surgical Pathology
|
August 28, 2007
Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group
Louis Guillou, Jean Benhattar, Carole Gengler, et al.
Acta Oncologica (Stockholm, Sweden)
|
April 23, 2017
Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study
Robin J Young, Saskia Litière, Michela Lia, et al.
Page
of 3